143 filings
Page 3 of 8
SC 14D9
PRVL
Prevail Therapeutics Inc.
22 Dec 20
Tender offer solicitation
8:33am
SC TO-T
PRVL
Prevail Therapeutics Inc.
22 Dec 20
Third party tender offer statement
7:07am
3
Tyto Acquisition Corp
16 Dec 20
Initial statement of insider ownership
8:07pm
SC14D9C
PRVL
Prevail Therapeutics Inc.
15 Dec 20
Written communication relating to third party tender offer
5:04pm
8-K
PRVL
Prevail Therapeutics Inc.
15 Dec 20
Lilly Announces Agreement to Acquire Prevail Therapeutics
9:12am
SC TO-C
LLY
Lilly(Eli) & Co
15 Dec 20
Information about tender offer
6:29am
10-Q
2020 Q3
PRVL
Prevail Therapeutics Inc.
Quarterly report
13 Nov 20
7:20am
8-K
PRVL
Prevail Therapeutics Inc.
13 Nov 20
Prevail Therapeutics Reports Third Quarter 2020 Financial Results and Business Highlights
7:09am
8-K
PRVL
Prevail Therapeutics Inc.
12 Nov 20
Regulation FD Disclosure
6:12am
8-K
PRVL
Prevail Therapeutics Inc.
2 Nov 20
Prevail Therapeutics Announces Decisive Victory in Arbitration Brought by Alector against Prevail’s CEO
7:22am
SC 13G
Citadel Advisors LLC
8 Oct 20
Prevail Therapeutics / CITADEL ADVISORS ownership change
4:02pm
4
William H. Carson
11 Sep 20
Prevail Therapeutics / William H. Carson ownership change
8:30am
3
PRVL
Prevail Therapeutics Inc.
11 Sep 20
Prevail Therapeutics / William H. Carson ownership change
8:28am
8-K
PRVL
Prevail Therapeutics Inc.
10 Sep 20
Prevail Therapeutics Announces Appointment of William H. Carson, M.D., to Board of Directors
4:26pm
424B5
PRVL
Prevail Therapeutics Inc.
11 Aug 20
Prospectus supplement for primary offering
8:40am
10-Q
2020 Q2
PRVL
Prevail Therapeutics Inc.
Quarterly report
11 Aug 20
7:09am
8-K
PRVL
Prevail Therapeutics Inc.
11 Aug 20
Prevail Therapeutics Reports Second Quarter 2020 Financial Results and Business Highlights
6:55am
EFFECT
PRVL
Prevail Therapeutics Inc.
9 Jul 20
Notice of effectiveness
12:15am
UPLOAD
PRVL
Prevail Therapeutics Inc.
7 Jul 20
Letter from SEC
12:00am
CORRESP
PRVL
Prevail Therapeutics Inc.
6 Jul 20
Correspondence with SEC
12:00am